Premium
Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis
Author(s) -
Jia Meng,
Zhu Li,
Zhai YaLing,
Chen Pei,
Xu BoYang,
Guo WeiYi,
Shi SuFang,
Liu LiJun,
Lv JiCheng,
Zhang Hong
Publication year - 2020
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.13580
Subject(s) - immunology , complement system , factor h , medicine , complement factor i , nephritis , nephropathy , glomerulonephritis , complement factor b , genotype , allele , genome wide association study , antibody , single nucleotide polymorphism , genetics , biology , kidney , gene , endocrinology , diabetes mellitus
Background Immunoglobulin A (IgA) vasculitis with nephritis (IgAVN) and IgA nephropathy (IgAN) are widely considered as related diseases. Considerable evidences support the notion of involvement of complement activation in both IgAVN and IgAN. Our previous studies identified a genetic variant in complement factor H ( CFH ), rs6677604, as an IgAN‐susceptible variant by genome‐wide association study, and further confirmed its linkage to CFHR3‐1Δ and proved its influence on complement activation and thereby on IgAN susceptibility. Aim To explore the role of rs6677604 in complement activation of IgAVN. Methods In this study, we enrolled 632 patients with IgAVN, 1178 patients with IgAN and 902 healthy controls. The genotype of rs6677604 was measured by TaqMan allele discrimination assays or was extracted from genome‐wide association study data. Results The frequency of the rs6677604‐A allele was significantly higher in IgAVN than in IgAN. However, no significant differences were observed between IgAVN and the controls. Higher complement factor H (FH) levels were observed in IgAVN than IgAN, and positive correlation between circulating FH and C3 levels was present in IgAVN. In both IgAVN and IgAN, rs6677604‐A was associated with less intensity of glomerular C3 deposits. In agreement with the higher frequency of rs6677604‐A in IgAVN, the glomerular C3 deposits of patients with IgAVN were less intense than those in IgAN. Conclusion Our findings suggest that genetic variation in CFH (rs6677604) is involved in the phenotype of complement activation in both IgAVN and IgAN. Moreover, rs6677604 might contribute to the difference of complement activation intensity between IgAVN and IgAN.